Indication
Decrease of intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- AzargaCanada · 1 % / W/V + 0.5 % / W/V · Suspension · Novartis Pharmaceuticals Canada INCSame brand
- Azarga 10 MG/ML + 5 MG/ML Colirio en SuspensionSpain · 5 mg + 10 mg · colirio en suspensión · Novartis Europharm LimitedSame brand
- AzargaCroatiaSame brand
- Azarga 10 mg/ml + 5 mg/ml oogdruppels, suspensieNetherlands · Oogdruppels, suspensie · Novartis Europharm LimitedSame brand